Molecular crowding may shift enzyme forms to preserve rapid antimicrobial defense
In blood-forming stem-cell descendants, molecular crowding may shift glucose-6-phosphate dehydrogenase forms and preserve rapid antimicrobial defense. Loss of the effect after controlling osmolarity, acidity and viscosity, or an effect confined to transcription changes, would argue against this mechanism.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Mechanics and load
Macromolecular crowding
The occupation of intracellular space by macromolecules, which limits the volume available to other molecules
Where this hypothesis actsIn descendants of haematopoietic stem cells before repeated infectious episodes
Hypotheses on this target 1
Inhibition
Activation
Function preservation
Remodelling
Load normalisation
Direct measurement
What is proposed
Reversibly alter the fraction of volume occupied by macromolecules
With whatNot stated in the record
HowVary crowding in a reconstructed reaction and cells of common origin, controlling osmolarity, acidity and viscosity
Possible result
Possible shifts in enzyme-form equilibrium, reducing-equivalent production and early microbial killing
From the recordобратимое изменение доли объёма, занятого макромолекулами, меняет образование восстановительного эквивалента и раннее уничтожение микроорганизмов.
Enzyme
Glucose-6-phosphate dehydrogenase
An enzyme whose catalytic activity supports production of reduced nicotinamide adenine dinucleotide phosphate
Where this hypothesis actsIn descendants of haematopoietic stem cells during attenuation of chronic inflammatory memory
Hypotheses on this target 1- Inhibition
- Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression- Function preservation1
What is proposed
Function preservation
Maintain sufficient catalytic activity while weakening chronic secretion
With whatPhysical or surgical intervention
HowAlter available cytoplasmic volume to shift the equilibrium between enzyme forms; measure their specific activities separately
Possible result
Possible preservation of the rapid antimicrobial oxidative response
From the recordизменения доступного объёма у потомков кроветворных стволовых клеток смещают равновесие между активными и малоактивными формами глюкозо-6-фосфатдегидрогеназы.
Rhythm or programme
Chromatin programme of chronic secretion
A chromatin-based programme that sustains chronic secretion
Where this hypothesis actsIn the inflammatory-memory setting of haematopoietic stem cells and their descendants
Hypotheses on this target 1- Inhibition1
- Activation
- Function preservation
Feedback restoration
Rhythm restoration- Direct measurement
What is proposed
Inhibition
Weaken the chromatin programme sustaining chronic secretion
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible reduction of chronic inflammation while preserving rapid defence if catalytic activity remains sufficient
From the recordХроматиновую программу хронической секреции можно ослабить с сохранением защиты лишь тогда, когда каталитическая активность этого пути остаётся достаточной.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Reducing lasting inflammation could come at the cost of weakening the body's next response to infection. The unexpected move is to make that tradeoff depend on the space available between large molecules inside immune cells, rather than only on which defensive instructions those cells retain. This is a proposal generated by the pipeline, not a measured separation of harmful inflammation from useful protection.
- Large molecules occupy space inside immune-cell descendants, changing the space available to the enzyme.
- The changed space is proposed to shift the balance between enzyme assemblies containing two units and those containing four units.
- The changed balance is proposed to alter reaction output according to the separately measured activity of each assembly; neither assembly is assumed to be inactive.
- Changed enzyme output is proposed to alter the rapid supply of reduced nicotinamide adenine dinucleotide phosphate, a molecule that carries electrons for chemical reactions.
- That supply supports the oxidative antimicrobial response, the production of reactive oxygen-containing chemicals used to attack microbes.
- Weakening the chromatin program, persistent control of gene use through DNA and its associated proteins, is proposed to reduce chronic inflammatory release while preserving rapid defense only if the enzyme pathway still supplies enough reducing power.
A crowded room can change whether people have space to stand in pairs or groups of four. If those arrangements perform a task at different speeds, changing the crowd could change output without changing the number of workers.
Where the picture breaks: Enzyme units do not choose arrangements like people do. The direction of the shift depends on molecular size, shape and interactions, and both arrangements can work; crowding alone does not establish which arrangement produces more output.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so changing a shared cause could benefit several body systems at once.
Rests on: The goal explicitly seeks shared causes whose targeted modification might extend life.
Stated in the chain - Goal pillarstep 02 of 04
Restoring function across the body should come with a limited burden of harm appearing later.
Rests on: The search for benefits across several systems is narrowed to the delayed costs of restoring their function.
AssumptionThe stage takes delayed harm from systemic restoration as a relevant target. The master question does not identify that harm or establish its connection to a shared cause of aging.
- Gap questionstep 03 of 04
Lasting changes left by inflammation in blood-forming stem cells, the cells that produce blood and immune cells, might contain separable instructions for chronic damage and rapid protection. Independently changing those retained instructions and the surrounding tissue before repeated infections is proposed as a way to distinguish them.
Rests on: The previous stage calls for limiting delayed harm, but does not identify retained inflammatory changes in blood-forming stem cells as its cause.
LeapThe supplied chain does not connect the delayed costs of systemic restoration to these cells or establish that their retained inflammatory changes contain distinct damaging and protective programs. The screened material does not supply that connection.
- Hypothesisstep 04 of 04
Space occupied by large molecules inside descendants of blood-forming stem cells is proposed to change the balance between forms of glucose-6-phosphate dehydrogenase, an enzyme that helps supply chemical reducing power. That balance could determine whether rapid microbial killing survives a reduction in the cell's lasting instructions to release inflammatory substances.
Rests on: The preceding question supplies the distinction between chronic damage and rapid protection, and separates retained cellular instructions from their surroundings. The endpoint supplies a proposed physical basis: large molecules exclude other molecules from the space they occupy, potentially changing how enzyme units assemble and function.
Stated in the chain
What is carried, and what is not. Three intermediate links have related evidence: enzyme assembly and activity, enzyme contribution to reducing-power supply, and enzyme contribution to the antimicrobial chemical response. In Phytomedicine (2025), S2 reports that a compound reduced two-unit assembly and activity without changing total enzyme abundance, but does not test molecular packing or immune protection; in Scientific Reports (2016), S8 supports the enzyme's contribution to reducing-power production in leukemia cell lines, but not this immune-cell mechanism; in Nature Chemical Biology (2020), S6 reports suppression of the rapid reactive-chemical response in neutrophils, a type of immune cell, after enzyme inhibition, but does not test packing or preservation of defense during reduced chronic inflammation, and none of these findings establishes the proposed sequence end to end.S2S8S6
Where the reasoning is carried by something unstated · 2
- Goal pillar. The stage takes delayed harm from systemic restoration as a relevant target. The master question does not identify that harm or establish its connection to a shared cause of aging.
- Gap question. The supplied chain does not connect the delayed costs of systemic restoration to these cells or establish that their retained inflammatory changes contain distinct damaging and protective programs. The screened material does not supply that connection. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Changing cell volume could change microbial killing through altered dissolved-particle concentration, acidity or resistance to molecular movement, then be credited to the space occupied by large molecules. What closes it: The proposal requires those three properties to be controlled. The occupied volume fraction must also be measured, rather than inferred from cell size alone, and the predicted enzyme-assembly shift must be checked in a reconstructed reaction outside cells.
- A shift between two-unit and four-unit enzyme assemblies could be mistaken for a change in useful reaction output. Both forms may be active, and the supplied equation predicts their balance rather than the speed of the whole reaction. What closes it: Measure each form's activity alongside assembly balance, reducing-power production and early microbial killing. The direction and magnitude predicted for the reconstructed reaction must be specified before comparison with its results.
- A rapid packing-dependent effect on microbial killing could be read as proof that chronic inflammatory harm and useful protection have been separated. It could instead show only that packing influences one protective reaction, while the rivals' proposed routes through inflammatory release, protective-protein production or chemical alteration of released proteins remain operative. What closes it: The full claim requires reduced chronic inflammatory release and preserved early killing to be demonstrated together, with enzyme amount, cell composition and chromatin state matched for the packing comparison. Measurements must also distinguish those rival routes; the supplied outline does not specify a complete comparison that does so.
What would make this wrong. The proposed excluded-volume mechanism would lose support if a verified, reversible change in molecular packing produced no predicted change in enzyme assembly, reducing-power production or early microbial killing under matched enzyme amount, cell composition and chromatin state. Effects that disappeared after controlling dissolved-particle concentration, acidity and resistance to molecular movement, or appeared only after changes in gene copying into working messages, would also contradict its distinguishing prediction. Even if the packing mechanism worked, failure to preserve rapid defense while reducing chronic inflammatory release would break the larger claim of functional separation.
What it would change. If the proposal held, a shared constraint on reducing harmful inflammation while retaining infection defense would include the physical conditions governing an enzyme reaction. Work on the master question would therefore need to assess retained protective capacity alongside reductions in inflammatory activity. Even a successful reconstructed reaction and cell test would not establish reduced damage across organs, protection through repeated infections, longer life or effectiveness in humans; the supplied test outline does not specify a species or a duration.
Sources read · 8
Ovatodiolide alleviates renal fibrosis through regulating metabolic reprogramming via targeting glucose-6-phosphate dehydrogenase. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
“Ova bound specifically to G6PD's Lys403 site, promoted its acetylation and thereby inhibited dimer formation and enzymatic activity without affecting overall protein expression.”
Does not settle: Источник не устанавливает влияние макромолекулярной скученности или доступного объёма на формы Г6ФДГ. Он также не изучает потомков кроветворных стволовых клеток, противомикробный окислительный ответ, образование НАДФН или хроматиновую программу хронической секреции.
Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation. · Redox biology · 2024
“In the present study, we demonstrated the lactylation modification of K45 inhibited the enzymatic activity of G6P, whereas HPV E6 prevent this modification and facilitate the formation of the active G6PD dimer.”
Does not settle: Источник не устанавливает влияние макромолекулярной скученности или доступного объёма на формы G6PD. Он также не изучает потомков кроветворных стволовых клеток, хроническое воспаление, противомикробный окислительный ответ или сохранение быстрой защиты.
“Additionally, our results show that G6PD enzyme activity and dimer formation are inhibited by HuaChanSu. Furthermore, we find that HuaChanSu could inhibit NADPH production and nucleotide level.”
Does not settle: Источник не устанавливает влияние макромолекулярной скученности или доступного объёма на формы Г6ФДГ, не исследует потомков кроветворных стволовых клеток, хроническое воспаление или противомикробный окислительный ответ.
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). · Blood cells, molecules & diseases · 2021
“inactivity of this enzyme may lead to shortage of NADPH and thus to insufficient activity of NADPH oxidase.”
Does not settle: Источник не устанавливает влияние макромолекулярной скученности или доступного объёма на формы и активность глюкозо-6-фосфатдегидрогеназы, не рассматривает потомков кроветворных стволовых клеток и хроническую секреторную программу.
A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. · Nature chemical biology · 2020
“In neutrophils, it suppresses respiratory burst.”
Does not settle: Источник показывает, что ингибирование G6PD подавляет респираторный взрыв нейтрофилов. Он не устанавливает роль макромолекулярной тесноты, доступного объёма, равновесия форм G6PD, потомков кроветворных стволовых клеток или сохранения быстрой защиты при ослаблении хронической секреторной программы.
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia. · Leukemia & lymphoma · 2017
“Glucose-6-phosphate dehydrogenase is an enzyme that leads to the production of NADPH, required to destroy microorganisms in the respiratory burst reaction of white blood cells.”
Does not settle: Источник не устанавливает влияние макромолекулярной скученности или доступного объёма на формы и активность глюкозо-6-фосфатдегидрогеназы. Он также не исследует потомков кроветворных стволовых клеток, хроническое воспаление или сохранение противомикробной защиты при ослаблении хроматиновой программы.
SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation. · Scientific reports · 2016
“These results suggest that G6PD is essential for cellular NADPH production in leukaemia cells.”
Does not settle: Источник показывает роль G6PD в выработке NADPH в клеточных линиях лейкоза. Он не устанавливает влияние макромолекулярной скученности или доступного объёма, равновесие форм G6PD, свойства потомков кроветворных стволовых клеток, противомикробный окислительный ответ или разделимость хронической воспалительной секреции и быстрой защиты.
The configurational length scale in the self-assembly and modulation of higher-order transient protein structures. · Proceedings of the National Academy of Sciences of the United States of America · 2025
“Previous work has indeed shown that molecular crowding can have substantial effects on the properties of biomolecules in plasma membranes as well as the cytoplasm ( ).”
Does not settle: Источник не устанавливает влияние исключённого объёма на равновесие форм глюкозо-6-фосфатдегидрогеназы, образование восстановленного никотинамидадениндинуклеотидфосфата, противомикробный окислительный ответ или хроническую воспалительную секрецию у потомков кроветворных стволовых клеток.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Can changing blood-forming stem-cell memory separately from its surroundings reduce lasting damage while preserving protection against repeated infections?
Original wording · exactly as the pipeline generated it
Можно ли причинно разделить воспалительную память кроветворных стволовых клеток на программу хронического повреждения и программу быстрой защиты, если независимо изменять клеточную память и тканевое окружение перед повторными инфекционными эпизодами?
What this question is asking
The question concerns lasting changes in blood-forming stem cells after inflammation, and whether their harmful and protective effects can be separated. It asks what happens when those lasting changes and the surrounding tissue are altered independently before repeated infections. The comparison is whether lasting damage can decrease while the body still limits the amount of infection in the first hours and days and retains that ability across later episodes. It assumes that cell memory and the surrounding tissue could contribute to both outcomes, but the supplied sources do not establish two distinct programs that can be independently controlled.
- Blood-forming stem cells
- Cells that can maintain their own population and produce the different types of blood cells, including immune cells. Lasting changes in these cells are the proposed starting point of the question.
- Progenitor cells
- Descendants of stem cells that produce a more restricted range of cell types. S2 discusses them together with blood-forming stem cells, so its statement is not limited to stem cells alone.
- Inflammation
- A collection of bodily responses to infection or injury. In this question, it is the earlier condition proposed to leave lasting changes in blood-forming cells; inflammation and lasting tissue damage are not interchangeable measurements.
- Cell memory or inflammatory memory
- A lasting alteration in how a cell responds after an earlier exposure, rather than conscious memory. Here it names a proposed persistent state, not an already identified single mechanism with proven harmful and protective components.
- Cellular program
- A coordinated pattern of activity within cells. Calling damage and protection separate programs does not establish that they have distinct causes or can be independently switched off.
- Tissue surroundings
- Nearby cells and the local conditions and signals that influence a cell. For blood-forming stem cells, the supplied sources discuss supporting surroundings within bone marrow.
- Bone marrow
- Tissue inside bones where blood cells are produced. It contains both blood-forming cells and cells that support and regulate them.
- Mesenchymal stromal cells
- A class of supporting cells that can release signals affecting other cells. In S7, their released signals are reported to leave blood-forming stem cells prepared for a later enhanced response.
- Emergency granulopoiesis
- An increased production of granulocytes, a group of immune cells, in response to urgent demand. This is the response described in S7; increased cell production alone does not establish reduced infection or reduced lasting damage.
- Chimeric mouse model and transplantation
- A research setting in which a mouse contains introduced cells from another source; transplantation is the transfer of those cells. S7 reports a response months after that transfer, which is a different timescale from measuring infection control during its first hours and days.
- Bacillus Calmette–Guérin vaccination
- The vaccination examined in S8 for its capacity to protect against viral disease. The supplied quote describes that protection as dependent on the disease process and tissues involved.
- Cellular metabolism and regulation of gene activity
- Cellular metabolism comprises the chemical processes through which cells obtain and use materials and energy. Regulation of gene activity controls how cells use their genetic instructions; S2 reports changes in both processes, without establishing their effects on repeated infections.
- Programmed cell death
- A regulated process through which a cell is eliminated. S3 discusses its control alongside cell division, rather than directly measuring the damage-versus-protection distinction in the question.
- Causal separation
- Distinguishing what each factor actually produces, rather than merely observing that factors change together. Here the factors are lasting states within blood-forming stem cells and influences from their surroundings.
- Chronic damage and protective capacity
- Chronic damage means continuing or lasting injury; protective capacity means the ability to limit infection, including during later episodes. They are outcomes requiring defined measurements, and the supplied material provides no numerical boundaries for either.
Inflammatory memory in blood-forming stem cells and signals from their tissue surroundings contribute to chronic damage and rapid protection as potentially separable programs.
Blood-forming stem cells produce blood and immune cells, while nearby supporting cells supply signals that influence their behavior. The assumption is that lasting changes within the stem cells and signals from those surroundings help determine both continuing injury and rapid defense against infection. If that holds, separating their contributions could explain whether reducing injury also removes protection.
S7 supports a narrower claim: signals released by supporting cells can leave blood-forming stem cells prepared for an enhanced response months after transplantation in mice. S2 reports changes in both blood-forming cells and supporting cells in diabetes, and S3 describes regulation by mechanisms inside stem cells together with signals from their surroundings. These findings do not establish that inflammatory memory causes both chronic damage and rapid protection, that these are distinct programs, or that their contributions have been independently separated before repeated infections.S2S3S7
The same question asked without the part nothing read establishes:
- Does independently changing lasting states in blood-forming stem cells and their surroundings affect chronic damage differently from early protection across repeated infections?
- What do lasting changes within blood-forming stem cells and signals from their surroundings each contribute to damage and protection during repeated infections?
- Damage falls and protection remains Under the question's proposed mechanism, a change would reduce the contribution to lasting injury while preserving early control of infection across later episodes. This would support functional separation under the conditions examined, although it would not by itself establish two distinct internal programs.
- Damage and protection fall together The change would reduce lasting injury but also weaken early control of infection or the ability to respond to later episodes. The apparent benefit from reduced damage would therefore come with a loss of defense; this outcome alone would not prove that a single internal program causes both effects.
- The outcome depends on the surroundings The same lasting cell state would produce different outcomes in different tissue surroundings. Protection or damage could then not be attributed to cell memory alone, and an effect observed in one setting would not establish the same tradeoff in another.
In the mechanism proposed by the question, an earlier inflammatory episode changes blood-forming stem cells, which can then change the supply or behavior of cells involved in later defenses. Signals from surrounding tissue could also influence these responses, making it difficult to attribute an outcome to memory inside the cells alone. If the same lasting change supports both damage and protection, removing it could reduce damage while weakening early control of infection. If those effects are separable, reducing damage would not necessarily require losing protection, but that separation is not demonstrated in the supplied evidence.
Узлы RL-1 описывают память предшественников и тканевых лимфоцитов; измерения RL-2 отслеживают состояния, но разделимость повреждения и защиты экспериментально не установлена.
После снижения воспаления инфекционная нагрузка ограничивается в первые часы и сутки; повторные эпизоды сохраняют защитный резерв в заданных границах.
Неизвестно, устраняет ли изменение памяти общий источник повреждения или одновременно расходует необходимый защитный резерв; причинность клеточной программы и окружения остаётся неразделённой.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Разделимость хронического воспаления и быстрой защиты определяется химической активностью ферментов в переполненном макромолекулами цитоплазматическом растворе. Предполагается, что изменения доступного объёма у потомков кроветворных стволовых клеток смещают равновесие между активными и малоактивными формами глюкозо-6-фосфатдегидрогеназы. Это меняет способность быстро образовывать восстановленный никотинамидадениндинуклеотидфосфат, необходимый для противомикробного окислительного ответа. Хроматиновую программу хронической секреции можно ослабить с сохранением защиты лишь тогда, когда каталитическая активность этого пути остаётся достаточной. Общее звено здесь представляет собой зависимость метаболической реакции от исключённого объёма.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Физическая химия упаковки и стерических ограничений. Для ассоциации двух димеров фермента D в тетрамер T используется термодинамическая поправка исключённого объёма: K_a(φ)/K_a(0) = exp[(2μ_D^ex(φ) - μ_T^ex(φ))/(RT)]. Здесь K_a = c_T/c_D² при одинаковой системе стандартных состояний; c_D и c_T обозначают концентрации димеров и тетрамеров; φ обозначает долю доступного цитоплазматического объёма, занятую прочими макромолекулами; μ_D^ex и μ_T^ex обозначают избыточные молярные химические потенциалы внесения соответствующих ферментных форм в такую среду; R является газовой постоянной, T в знаменателе обозначает абсолютную температуру. Во избежание неоднозначности символа тетрамер при расчётах следует обозначить E4. Геометрия и размеры ферментных форм входят в оценку химических потенциалов. Обе формы могут быть активны, поэтому их удельные активности измеряются отдельно. Уравнение задаёт проверяемое равновесие, но само по себе не определяет скорость всей реакции.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых количестве фермента, составе клеток и состоянии хроматина обратимое изменение доли объёма, занятого макромолекулами, меняет образование восстановительного эквивалента и раннее уничтожение микроорганизмов. Эффект возникает до изменения транскрипции. В бесклеточной реконструкции воспроизводятся направление и величина сдвига равновесия ферментных форм. Если влияние исчезает после контроля осмолярности, кислотности и вязкости либо сопровождается только изменением транскрипции, гипотеза исключённого объёма теряет поддержку.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable changes under controlled conditions, temporal ordering, reproduction of the direction and magnitude of an equilibrium shift, and explicit conditions that would weaken support. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Доступны измерения клеточного объёма и сухой массы, молекулярные датчики переполненности, анализ ферментной активности и метаболических потоков. Причинную проверку разумно начинать с реконструированной реакции и клеток одного происхождения: изменение объёма целой клетки имеет много побочных эффектов.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых количестве фермента, составе клеток и состоянии хроматина обратимое изменение доли объёма, занятого макромолекулами, меняет образование восстановительного эквивалента и раннее уничтожение микроорганизмов. Эффект возникает до изменения транскрипции. В бесклеточной реконструкции воспроизводятся направление и величина сдвига равновесия ферментных форм. Если влияние исчезает после контроля осмолярности, кислотности и вязкости либо сопровождается только изменением транскрипции, гипотеза исключённого объёма теряет поддержку.
- Rival 01 of 03What would separate them
Interleukin-6 from blood-forming stem cells may sustain organ damage while preserving defense predicts: После формирования памяти ограниченное стволовыми клетками выключение синтеза интерлейкина-6 снижает его межэпизодный уровень и последующее повреждение лёгких и почек раньше обновления зрелых миелоидных клеток. Численность, состояние хроматина и ранняя противомикробная активность этих клеток остаются сопоставимыми с контролем. Восстановление измеренного физиологического потока интерлейкина-6 возвращает повреждение. Отсутствие достаточного потока из стволовых клеток или появление эффекта только после смены потомков опровергает центральное утверждение.
- What would separate them
Queuosine modification may separate antimicrobial protection from inflammatory damage predicts: При одинаковом количестве матричной РНК изменение квеозиновой модификации меняет отношение синтеза выбранных защитных и повреждающих белков. Зависимость защитного белка от модификации исчезает после синонимической замены чувствительных кодонов при сохранении его аминокислотной последовательности и сопоставимых количества и стабильности матричной РНК. Такая замена восстанавливает раннюю защитную функцию после ослабления воспалительной памяти. Сохранение эффекта после замены кодонов либо отсутствие различий между защитным и повреждающим наборами белков опровергает предложенное разделение.
- What would separate them
Carbamylation may turn protective cathelicidins into tissue-damaging molecules predicts: При одинаковой секреции кателицидина и одинаковой ранней инфекционной нагрузке повреждение ткани определяется долей конкретных карбамилированных форм. Химически определённая N-концевая модификация человеческого LL-37 повышает повреждение клеток хозяина при сохранении бактерицидного эффекта в подходящей модели. Ограничение образования этой формы уменьшает повреждение, а её добавление в измеренной физиологической концентрации возвращает его. Отсутствие достаточного количества модифицированного пептида in vivo или эффекта его избирательной замены опровергает механизм.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.